Science Explorer Interactive view Map
Topic · Surgery

Esophageal and GI Pathology

Esophageal and GI Pathology is a research topic within Surgery. Science Explorer counts 58k research works in it since 1950. 11.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the evolving techniques and advancements in the management of esophageal perforation, endoscopic stenting for benign and malignant diseases, palliative treatment of gastric outlet obstruction using self-expanding metal stents, and the use of endoluminal vacuum therapy. It also covers topics such as esophageal atresia, tracheoesophageal fistula, and the management of anastomotic leaks.

  • Esophageal Perforation
  • Endoscopic Stenting
  • Gastric Outlet Obstruction
  • Self-Expanding Metal Stents
  • Benign and Malignant Diseases
  • Anastomotic Leaks
  • Esophageal Atresia
  • Tracheoesophageal Fistula
  • Endoluminal Vacuum Therapy
  • Palliative Treatment
Research works
58k
fractional, since 1950
In the world top 10%
6.9k
per year above
Top-10% rate
11.9%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+24%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Esophageal and GI Pathology research?

By volume, the United States and China publish the most (2.2k and 1.1k works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 2.2k works
  2. 2 China 1.1k works
  3. 3 Japan 1.1k works
  4. 4 India 547 works
  5. 5 United Kingdom 518 works
  6. 6 Italy 361 works
  7. 7 Germany 341 works
  8. 8 Spain 273 works
  9. 9 Brazil 246 works
  10. 10 South Korea 241 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.5%China: 16.5%Japan: 15.3%India: 7.9%6 others listed: 28.8%31%largest
United States2,166 · 31.5%China1,136 · 16.5%Japan1,053 · 15.3%India547 · 7.9%6 others listed1,980 · 28.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Esophageal and GI Pathology research?

By volume in 2022–2025, Cleveland Clinic publishes the most Esophageal and GI Pathology research, followed by Mayo Clinic in Arizona and First Affiliated Hospital of Zhengzhou University.

By volume, 2022–2025

  1. 1 Cleveland ClinicUnited States 36 works
  2. 2 Mayo Clinic in ArizonaUnited States 30 works
  3. 3 First Affiliated Hospital of Zhengzhou UniversityChina 30 works
  4. 4 All India Institute of Medical SciencesIndia 30 works
  5. 5 University College LondonUnited Kingdom 28 works
  6. 6 Ain Shams UniversityEgypt 27 works
  7. 7 University of North Carolina at Chapel HillUnited States 26 works
  8. 8 Sichuan UniversityChina 25 works
  9. 9 Sağlık Bilimleri ÜniversitesiTürkiye 23 works
  10. 10 Post Graduate Institute of Medical Education and ResearchIndia 23 works

Where is Esophageal and GI Pathology research done?

The largest centres of Esophageal and GI Pathology research in 2022–2025 are Tokyo (Japan), London (United Kingdom), Beijing (China) and Seoul (South Korea).

Largest cities, 2022–2025

  1. 1 Tokyo Japan 247 works
  2. 2 London United Kingdom 158 works
  3. 3 Beijing China 122 works
  4. 4 Seoul South Korea 108 works
  5. 5 Shanghai China 96 works
  6. 6 New York United States 91 works
  7. 7 Moscow Russia 80 works
  8. 8 Chengdu China 79 works
  9. 9 São Paulo Brazil 76 works
  10. 10 Osaka Japan 75 works
See Esophageal and GI Pathology on the map

Where is the best place to study Esophageal and GI Pathology?

Among universities, judged by research, Humanitas University, Vita-Salute San Raffaele University and SHOWA Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 14.05%fractional works in this node (log) →share in the world top 10% →Humanitas University: 10, 13.8%Vita-Salute San Raffaele University: 11, 14.6%SHOWA Medical University: 9, 13.6%Kansai Medical University: 9, 22.4%Saitama Medical University: 15, 13.7%Jikei University School of Medicine: 10, 14.6%Tokyo Medical University: 15, 8.5%Juntendo University: 12, 9.4%Carol Davila University of Medicine and Pharmacy: 11, 7.8%University of Milan: 12, 22.1%Kansai Medical Unive…Vita-Salute San Raff…Humanitas UniversitySHOWA Medical Univer…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Humanitas UniversityItaly 59.213.8%13.1×10 +176.4%
2 Vita-Salute San Raffaele UniversityItaly 58.014.6%9.0×11 +169.2%
3 SHOWA Medical UniversityJapan 55.113.6%14.3×9 +370.5%
4 Kansai Medical UniversityJapan 53.922.4%17.8×9 +46.7%
5 Saitama Medical UniversityJapan 51.313.7%23.7×15 +22.4%
6 Jikei University School of MedicineJapan 50.214.6%11.8×10 +86.6%
7 Tokyo Medical UniversityJapan 48.38.5%23.8×15 +56.8%
8 Juntendo UniversityJapan 47.49.4%8.7×12 +109.6%
9 Carol Davila University of Medicine and PharmacyRomania 46.17.8%7.3×11 +271.3%
10 University of MilanItaly 45.722.1%2.0×12 +140.1%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Esophageal and GI Pathology research growing?

Output in 2018–2022 was 24% higher than in 2013–2017, peaking in 2020. The fastest-growing topics are Esophageal and GI Pathology.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.